Notice of NHGRI Participation in PAR-23-309, “Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)”
Notice Number:

Key Dates

Release Date:

November 15, 2023

Related Announcements

  • September 26, 2023 - Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional). See NOFO PAR-23-309.
  • August 31, 2022 - NHGRI implementation of NIH Policy on Acceptance for Review of Applications Requesting $500,000 or More in Direct Costs in a Single Year. See Notice NOT-HG-22-003.

Issued by

National Human Genome Research Institute (NHGRI)


The purpose of this notice is to inform potential applicants that the National Human Genome Research Institute (NHGRI) will participate, effective immediately, in PAR-23-309, “Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)."

The following sections of PAR-23-309  have been modified (changes in italics) to reflect the participation of NHGRI in this NOFO.

Part 1. Overview Information

Participating Organization(s)

National Institutes of Health (NIH)

Components of Participating Organizations

National Institute on Minority Health and Health Disparities (NIMHD)

National Eye Institute (NEI)

National Human Genome Research Institute (NHGRI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute on Deafness and Other Communication Disorders (NIDCD)

National Institute of Neurological Disorders and Stroke (NINDS)

National Institute of Nursing Research (NINR)

National Cancer Institute (NCI)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Sexual and Gender Minority Research Office (SGMRO)

Office of Behavioral and Social Sciences Research (OBSSR)

Assistance Listing Number(s)

93.307, 93.173,  93.172, 93.865, 93.286, 93.361, 93.867, 93.273, 93.866, 93.399, 93.846, 93.853

Part 2. Full Text of Announcement

Section I. Notice of Funding Opportunity Description

Key Definitions

NIH-designated Populations Experiencing Health Disparities: Racial and ethnic minority populations, socioeconomically disadvantaged populations, underserved rural populations, sexual and gender minority groups, and people living with disabilities in the U.S.

Disability: The Americans with Disabilities Act broadly defines a disability as a "physical or mental impairment that substantially limits one or more major life activities” (e.g., mobility, cognition, independent living, vision, and self-care) and the ADA Amendments Act of 2008 that added "major bodily functions", to "Major Life Activities." This funding opportunity focuses on persons across the lifespan with congenital, developmental, cognitive, and physical disabilities (e.g., Down's syndrome, cerebral palsy, or injury-related physical impairment or amputation), as well as adults with early or premature onset of a major physical disability – that causes long-term impairment or limit(s) functioning indefinitely.

Intersectional Approach: Intersectionality acknowledges that individuals have multiple, interconnected social identities (e.g., gender, racial group, class, sexual orientation, and disability), and these identities intersect to shape their unique experiences and positions within society. For example, intersectionality highlights how racial and ethnic minority persons living with a disability may experience a unique set of challenges that require a more comprehensive approach to addressing discrimination and promoting health equity. Taking an intersectional approach can better predict variations in health outcomes and determine individual or population needs, and ultimately lead to more inclusive and/or multi-level research.


The population of persons living with disabilities in the United States is heterogeneous, estimated at 24-26% of adults and 4.3% of children from various backgrounds, life circumstances, and health conditions. Impaired mobility (13.7%), cognition (10.8%), and independent living (6.8%) are the most common disabilities among adults, and impaired cognition (4.4%) is most common among children. Data indicate that, on average, individuals living with disabilities have poorer health-related quality of life and overall health, as well as decreased healthy life expectancy and longevity compared with people without a disability. Adults living with disabilities have a higher prevalence of preventable, chronic, and complicating comorbidities compared with the overall adult population. Examples include obesity (38.2% versus 26.2%), tobacco smoking (28.2% versus 13.4%), diabetes (16.3% versus 7.2%), and heart disease (11.5% versus 3.8%). Among persons of childbearing age, 12% live with at least one disability and are at a higher risk for maternal morbidity and mortality. Additionally, the objective signs and subjective experiences of persons living with disabilities are often dynamic, changing in nature, quality, and severity over time.

Research Objectives:

The focus of this notice of funding opportunity (NOFO) is to emphasize research at the intersection of disabilities, race and ethnicity, and socioeconomic status (SES) in persons with developmental and physical disabilities.  Among racial and ethnic minority groups, the prevalence of living with at least one disability is markedly greater in American Indian and Alaska Native (30%) and Black or African American (25%) populations compared to 20% of White persons. Irrespective of racial and ethnic group, economically disadvantaged persons with disabilities are more likely to experience diminished opportunities for effective independent living driven by factors such as unemployment, adverse living conditions, housing instability, food insecurity, transportation limitations, social isolation, disaster unpreparedness, and low quality of healthcare.  Additionally, residents of underserved rural communities are 9% more likely to have any disability and 24% more likely to report having three or more disabilities compared with adults in urban areas. Individuals living with disabilities, who reside in rural areas may also face barriers to healthcare access, accessible transportation, and high-quality education, and vocational or rehabilitation services. Research among sexual and gender minority persons with disabilities is scarce, although it is likely that commonly experienced barriers to accessing culturally competent physical, psychiatric, and specialty healthcare are intensified.

Furthermore, adverse social determinants of health (SDOH) amplify the challenges of health and health-related quality of life (QoL) among youth and adults living with disabilities. Examples include lack of accessible transportation or building entry/navigation, discrimination related to ableism, and clinical misperceptions within healthcare systems that may greatly complicate healthcare access and quality. Moreover, inaccessible and/or non-adaptive clinical facilities, equipment, and communication mechanisms, as well as non-inclusive clinical care guidelines and procedures impede equitable access to appropriate healthcare or lead to erroneous attribution of symptoms related to the primary disability rather than a new or co-occurring diagnosis or health crisis. Greater study is needed to inform appropriate or adaptable clinical practice guidelines for persons living with disabilities with an intersectional lens, as well as to enhance the understanding of the health and health risk behaviors (e.g., alcohol and substance use, prescription misuse, self-injurious behaviors, and interpersonal violence) over the life course. Overall, more expansive research is needed to elucidate the discrete differences, areas of overlap, relationships among factors across the lifespan, and severity of health outcomes across and within populations with health disparities. Therefore, this funding opportunity strongly encourages collaborative, mechanistic, clinical, or interventional research, implementation or translational science, and/or the use of data science research approaches in intersectional areas of study.

Research Objectives:

The overarching goals of this funding opportunity are to support innovative research that focuses on the health (e.g., conditions, outcomes, trajectories, etc.) and healthcare (e.g., modalities systemic or structural factors, access/barriers, service delivery, care quality, utilization, etc.) of persons living with disabilities and the intersections with race and ethnicity, and SES. Research focused on intersections with sexual and gender minority self-identification, and living in underserved rural locations are also of interest.

Projects may include the study of comorbid or co-occurring conditions (e.g., acute infections or chronic diseases); adaptive and maladaptive behaviors; prevention of or interventions for health risks; tailored or innovative health care processes, structures, or systems; healthcare delivery model effectiveness; and clinicians and other health care workers’ practices and/or biases.

Applications are expected to provide a conceptual model that describes or hypothesizes causal pathways by which clinicians and other healthcare professionals, services, or systems engage persons with disabilities to mitigate health risks, improve health outcomes, reduce health disparities, or compliment health care system.

Applications are encouraged to address more than one level of analysis (e.g., individual, interpersonal, institutional, community, and policy levels), as illustrated in the NIMHD Research Framework. They should also consider factors that will facilitate or serve as barriers to sustainability and/or adoption of healthcare models, practices, or guidelines. Resulting research initiatives will support science that advances our understanding of and efforts to mitigate the underlying causes and pathways adversely impacting the populations of focus.

Research projects for this NOFO can consist of studies that are clinical science, behavioral, epidemiological, evaluative, or observational, as well as implementation studies, pragmatic trials, and cluster randomized trials to assess health care provision, models, delivery, services, and systems in metropolitan or rural areas, regionally, and/or nationally, including the U.S. territories. Projects can involve primary data collection and/or secondary analyses of linked datasets. Projects can include research collaborations across multiple health care settings and academic institutions.

Investigators are strongly encouraged to work collaboratively with community leaders, community-based organizations, and other relevant stakeholders and/or supporting persons with disabilities to support in-depth examination of physical, social, behavioral, ethical, structural, environmental, and policy factors. Community partnerships (e.g., tribal leadership, academic, private, safety-net health systems, community organizations, public health departments, state and local governments, health care professionals, faith-based organizations, and school or childcare settings) are strongly encouraged. Applicants proposing community-engaged research should document existing collaboration with or support from community organizations. Study budgets should provide appropriate levels of funding for community partners commensurate with the roles and level of effort of the community partners in research design and implementation, if applicable.

National Institute of Minority Health and Health Disparities (NIMHD)

The mission of NIMHD is to lead scientific research to improve minority health and reduce health disparities. For this funding opportunity, NIMHD priorities include research that employs an intersectional approach to the study of, or interventions targeting, the health and healthcare of persons living with disabilities. Areas of interest include, but are not limited to, the following:

  • Population-based studies of health risks, associated SDOH, trends, potential causes of disparities that identify and address:
    • Population health strategies to reduce complicating health risks and/or to strengthen protective individual, community, and/or healthcare system factors.
    • Multilevel studies to understand the influence of factors at varying or intersecting levels (e.g., individual, interpersonal, or community).
  • Multilevel examination or evaluation of healthcare systems and clinical and community infrastructures, and social and ancillary services influencing health outcomes, which address:
    • Factors and mechanisms influencing healthcare access, delivery, quality, utilization, screening, treatment, medical specialty/surgical referrals, and disaster/emergency preparedness, response and recovery.
    • Developmentally appropriate, patient-centered, and wrap-around care coordination.
    • Effectiveness of training models and practices focused on disability competencies and structural biases (e.g., ableism).
  • Development, testing, implementation, and/or evaluation of integrative care models and interventions to optimize care, which address:
    • Factors affecting adaptation, inclusivity, and equity of comprehensive health care and services.
    • Specific access barriers (e.g., digital exclusion)
    • Clinical practice guidelines or processes (e.g., decision-making, communication, care coordination, behaviors, multi-specialty collaboration, healthcare system communication) for the prevention, diagnosis, care, and management of multiple and/complex conditions at different levels or components within health care systems.
    • Unique manifestation of non-communicable and chronic diseases in these populations, thus leading towards tailored and timelier preventive, diagnostic and treatment strategies, especially within the context of racial/ethnic self-identification and/or low SES.
  • Studies of comprehensive behavioral interventions and social care services influencing health outcomes, and quality of lifewhich address:
    • Clinical, community, or home-based prevention and interventions to improve instrumental activities of daily living (e.g., self-care, domestic tasks, managing finances, and transportation) and self-agency.
    • Interventions to improve behavioral healthcare, mental healthcare care access, engagement, and quality.
    • Intervention and policy development and evaluation to support community living, inclusion, and independence.
  • Community-engaged or community-based participatory research that engages persons living with disabilities and/or their families with lived experience, as well as community partners to understand or mitigate health risks and/or improve protective factors and health outcomes.
  • Conceptualizations or perceptions of social norms (e.g., ableism), attitudes, and behaviors (e.g., discriminatory practices) influencing individual- and population-level healthcare engagement, health practices, quality of life, and well-being.

Specific Areas of Research Interest for Participating Organizations:

National Cancer Institute (NCI)

The NCI is interested in promoting research that addresses access and barriers to the delivery and receipt of cancer care that contribute to health disparities for persons with physical and/or sensory disabilities (PWD).  Our focus on PWD who have a pre-existing/pre-cancer physical and/or sensory (e.g., vision loss, hearing loss) disability. NCI seeks to generate new knowledge that will help mitigate the stigma of disability and improve access to and delivery of guideline-concordant cancer preventive care and treatment, and utilization of cancer services, particularly for PWD who are members of medically underserved minority or marginalized groups (e.g., racial/ethnic minorities, sexual and gender minorities). Applicants should consider the architectural/environmental, structural, interpersonal, and procedural barriers that limit access to guideline-concordant cancer care.

   Research areas of interest include, but are not limited to the following:

  • Identify architectural, structural, interpersonal, and procedural features that are associated with PWD receiving timely guideline-concordant cancer care (including screening, testing, treatment, palliative care, and pain management)
  • Develop, test, and evaluate/implement strategies to improve cancer care coordination and follow-up care for PWD, particularly medically underserved individuals, such as racial/ethnic minorities, sexual and gender minorities, members of underserved rural and urban communities, and those living far from cancer care facilities
  • Examine how telehealth and technology can be employed to improve cancer screening, diagnosis, treatment, care management, and follow-up for PWD; Develop, test, and evaluate/implement technology to improve access to cancer care for PWD
  • Identify models or elements of patient-provider communication that facilitate recommendations for screening and receipt of guideline-concordant cancer care for PWD
  • Identify factors associated with failing to follow up with screening recommendations or adhering to treatment plans for PWD; Develop, test, evaluate/implement strategies that improve adherence to screening and treatment recommendations
  • Identify characteristics or features of the hospital/clinic/doctor’s office building and office environment that facilitate access to care and contribute to patient satisfaction
  • Identify multi-level barriers to participating in clinical research faced by PWD; Develop, test, evaluate/implement strategies to reduce or eliminate barriers so that PWD are eligible to be included in clinical research

National Eye Institute (NEI)

The mission of NEI is to eliminate vision loss and improve quality of life through vision research.  NEI invites intersectional research applications that address the health and well-being for people with visual impairment (blindness and low vision) among populations with health disparities. More information regarding NEI priorities are detailed in the institute’s strategic plan

   Areas of specific interest include but are not limited to the following:

  • Intersectional factors that disadvantage or protect access to healthcare and/or sociocultural services among populations with health disparities who are visually impaired
  • Multilevel research to address comorbidities that accompany visual impairment in populations with health disparities and their integrated care management
  • Development of implementation strategies and translational science approaches to address visual impairment in populations with health disparities
  • Intersectional research on the impact of stigma and ableism on the health and wellness of populations with health disparities who have visual impairments

The NEI will not support clinical trials that are greater than minimal risk on this funding opportunity.  Minimal risk is defined as the probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests.  For additional information on NEI Clinical Trial policies, see NOT-EY-23-001. Applicants are strongly advised to reach out to the NEI Scientific Contact before submitting applications for guidance about NEI’s interests and more information regarding clinical trial designations.

National Human Genome Research Institute (NHGRI)

NHGRI supports resources, approaches, and technologies that accelerate genomic research focused on the structure and biology of genomes; the genomics of disease; the implementation and effectiveness of genomic medicine; computational genomics and data science; the impact of genomic technology, advances, and implementation on health disparities and health equity; and ethical, legal, and social issues related to genomic advances. NHGRI recognizes the  importance of diversity in the genomic workforce , without which the promise of genomics cannot be fully achieved.

In general, NHGRI supports studies that provide generalizable methods and knowledge. Approaches that are comprehensive across the genome or are generalizable across variants, tissues, diseases, or function may be in scope for NHGRI to the extent they address priority areas described in the  NHGRI 2020 Strategic Vision  and on the web pages for the research mission of NHGRI’s Extramural Divisions and Offices:

Applications for studies relevant only to a particular disease or organ system should be directed to the appropriate Institute or Center. Applications whose primary scientific objective is to understand a single biological or behavioral process, the pathophysiology of a disease, or the mechanism of action of an intervention, will not be in scope for NHGRI.

Additionally, as described in NOT-HG-22-033, NHGRI  strongly encourages that the request for an application requesting $500,000 or more in direct costs for any year be sent to the Scientific/Research Contact for  PAR-23-309 at least eight weeks prior to the anticipated submission date.

National Institute on Aging (NIA)

The mission of NIA is to support and conduct genetic, biological, clinical, behavioral, social, and economic research on aging; foster the development of research and clinician scientists in aging; provide research resources; and disseminate information about aging and advances in research to the public, health care professionals, and the scientific community, among a variety of audiences.

NIA uses the definition of disability provided in the Americans with Disabilities Act and ADA Amendments Act of 2008 that added "major bodily functions", to "Major Life Activities".

NIA has the following research interests related to persons living with disabilities:

  • Aging-related studies spanning disabilities that are congenital, developmental, and/or acquired.
  • Research of co-occurring Alzheimer’s Disease and Related Dementias.
  • Intersections between disability status and racial/ethnic identity(ies), sexual and gender identity(ies), as well as socioeconomic status, among older Americans, utilizing the NIA Health Disparities Framework. Such research should hold the potential to illuminate the distinct challenges faced by individuals with disabilities in terms of accessing healthcare services, navigating complex healthcare systems, and enhancing their overall well-being. Particularly, NIA has an interest in the challenges people living with disabilities face, among those residing in rural areas and individuals who have been or currently are incarcerated.
  • NIA is also interested in how risk and protective factors (e.g., poverty and economic vulnerability, segregation, racism, ableism, sexism, ageism, immigration, loneliness, social support, educational attainment, culture, and spirituality) play a role in disability in explaining health disparities. NIA also seeks to identify and understand how protective factors help to counteract the effects of risk factors, in studies that use an experimental medicine approach.
  • Older adult adaptive and maladaptive behaviors, health risk prevention, and intervention development aligned with the NIH Stage Model for Behavioral Intervention Development and Science of Behavior Change, which can have direct relevance to older populations striving to maintain their health and independence.

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

The mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases. In the context of this NOFO, the NIAMS is interested in intersectional research into improving the health and health care of individuals living with disability among populations that experience health disparities and are patients suffering from a disease within NIAMS’ core mission. The NIAMS will not support clinical trials through this NOFO. Applications involving clinical trials should instead be submitted to a NIAMS clinical trial specific NOFO (see Clinical Research Grants).  Applicants are encouraged to consult with the appropriate NIAMS program staff about potential applications. 

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

This mission of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) is to transform through engineering the understanding of disease and its prevention, detection, diagnosis, and treatment. NIBIB is interested in projects that address specific needs of populations with disabilities that are experiencing health disparities. Projects may span the development in research settings, validation, translation into clinical settings as needed, and incorporation of these solutions as endpoints into research protocols. Applications developing novel technologies should incorporate a universal design approach and those building on existing technologies should provide significantly improved accessibility and ease-of-use for all.

Research areas of special interest include, but are not limited to the following:

  • Examine how PWD are represented in current technology development efforts; Identify multi-level barriers to technology use faced by PWD
  • Develop, test, or implement technologies to reduce or eliminate barriers for PWD in clinical research
  • Analyze intersectional factors that restrict access to imaging or point of care technologies

For applications proposing clinical trials, NIBIB funding of clinical trials will be in accordance with NOT-EB-21-005 “NIBIB Guidance for Support of Clinical Trial Applications." Briefly, NIBIB will only support mission-focused early-stage clinical trial applications, i.e., feasibility, Phase I, first-in-human, safety, or other small clinical trials, that inform early-stage technology development. NIBIB will not support applications proposing pivotal, Phase II, III, IV, or trials in which the primary outcome is efficacy, effectiveness, or a post-market concern. Also, mechanistic trials are not supported unless the primary focus of the project is on technology development.

Applicants are strongly advised to reach out to the NIBIB Scientific Contact before submitting applications for guidance about NIBIB’s interests and more information regarding clinical trial designations.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NICHD’s mission is to lead research and training to understand human development, improve reproductive health, enhance the lives of children and adolescents, and optimize abilities for all. NICHD is interested in projects at the intersection of disability and individuals’ other identities, including how multiple identities might interact to exacerbate health disparities. Applications seeking to establish the efficacy or effectiveness of novel interventions should address scalability and sustainability and fully consider the context in which such interventions will be implemented. Visit and for more information about NICHD research priorities.

  Research areas of interest include, but are not limited to:

  • Access to pregnancy and reproductive health care in people living with disabilities among populations experiencing health disparities.
  • Intersectionality of identities linked with health disparities and maternal health outcomes in people with disabilities.
  • Prenatal and postnatal development drivers of disability in populations experiencing health disparities.
  • Intersectional factors that disadvantage and/or protect access to quality services among populations experiencing health disparities who are living with disabilities.
  • Drivers of disability childhood development through adolescence in populations experiencing health disparities.
  • The role of multiple identities in driving accessibility barriers that disrupt health care services and constrain opportunities to seek and use of preventive and treatment services among people with disabilities.
  • Interactions between multiple identities and their role in driving ableist attitudes among healthcare providers and health systems and the quality-of-care people with disabilities receive.
  • Multilevel approaches to understanding intersectionality and its role in driving disparate rehabilitation outcomes among people with disabilities who also identify as a member of one or more populations experiencing disparities.

National Institute on Drug Abuse (NIDA)

The mission of NIDA is to advance science on the causes and consequences of drug use and addiction and to apply that knowledge to improve individual and public health. NIDA is interested in supporting research relevant to advancing the understanding of the effects of substance use among people living with disabilities and experiencing health disparities. This includes the identification and development of innovative strategies, prevention, and intervention methods, as well as policy changes to reduce negative effects of substance use among this population, specifically among racial and ethnic minorities, sexual and gender minorities, and other underserved populations. Priority areas include but are not limited to research on the following:

  • How limited accessibility impacts substance use treatment and services.
  • What are the substance use risks and potential compounded health disparities of underserved populations living with disabilities?
  • Using an intersectional lens to examine substance use risk and protective factors among underserved populations living with disabilities, including exploring availability and use (or lack thereof) of prevention services.
  • Implementation science and health systems research to understand the impact of accessibility on substance use prevention and treatment efforts.
  • How limited accessibility and barriers to accessibility impact seeking out and use of prevention and treatment services (transportation, adequate parking at treatment facilities, SUD counseling that isn’t adapted for people with cognitive disabilities, no materials in Braille or other alternative formats, lack of staff training on technologies for communicating with people who are deaf, etc.).
  • What is the impact of stress among this population that can lead to substance use and/or addiction, and how can community services alleviate stress to facilitate the substance use intervention process.
  • What is the impact of stigma against underserved populations living with disabilities and how that affects seeking and use of substance use prevention and treatment services.
  • What gaps exist in medical and community settings that may prevent adequate addiction services to underserved populations living with disabilities.
  • Evaluating financial issues that may stem from living with a disability and lead to substance use. How unemployment due to a disability impacts substance use. How do the combined costs of substance use services and accessibility accommodations impact the uptake and use of substance use services and outcomes?
  • Development of substance use prevention and intervention strategies among underserved populations living with disabilities.

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIDCD invites responsive applications addressing the needs of individuals with communication disorders, specifically those disorders that align with the Institute’s scientific programs of hearing, balance, taste, smell, voice, speech, and language.  For more information, please see: Any applications proposing a clinical trial must meet ALL the following criteria: not require FDA oversight, are not intended to formally establish efficacy, and have low risks to potentially cause physical or psychological harm. Application funded by NIDCD should have budgets less than $500,000 direct costs per year.

National Institute of Neurological Disorders and Stroke (NINDS)
The National Institute of Neurological Disorders and Stroke (NINDS) is interested in applications within the NINDS mission (NINDS Disorders Index: NINDS aims to support multidisciplinary, community-engaged health equity research to identify develop, and evaluate strategies to improve outcomes specifically related to neurological disorders in people living with disabilities among populations experiencing health disparities. Specific areas of research interest include but are not limited to:

  • Identify and validate approaches to examine the role of stigma, bias, ableism, and/or discrimination as risk factors contributing to neurological health disparities in persons living with disabilities among NIH-designated HDPs.
  • Identify and measure specific modifiable social determinants of health that contribute to neurological health disparities in persons living with disabilities among NIH-designated HDPs.
  • Identify strategies to address structural barriers, organizational practices, policies and other social, cultural, and contextual factors that impact disparate neurological health outcomes in persons living with disabilities among NIH-designated HDPs.

Clinical trials are research studies in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes. For this funding announcement, only Basic Experimental Studies with Humans (BESH) clinical trials, defined as basic research studies involving humans that seek to understand the fundamental aspects of phenomena will be supported by NINDS.  Mechanistic clinical trials or clinical trials that seek to answer specific questions about safety, tolerability, clinical efficacy, effectiveness, clinical management, and/or implementation of pharmacologic, behavioral, biologic, surgical, or device (invasive or non-invasive) interventions, preventive, therapeutic, and services interventions will not be supported under this NOFO. Please refer to to find the appropriate NIH or NINDS-specific NOFO for such clinical trials. Applicants are strongly advised to consult with NINDS prior to submitting an application to this NOFO to determine the appropriate funding

National Institute of Nursing Research (NINR)

The NINR supports research to solve pressing health challenges and inform practice and policy – optimizing health and advancing health equity into the future. NINR discovers solutions to health challenges through the lenses of health equity, social determinants of health, population and community health, prevention and health promotion, and systems and models of care. Drawing on the strengths of nursing’s holistic, contextualized perspective, core values, and broad reach, NINR funds multilevel and cross-sectional  research that examines the factors that impact health across the many settings in which nurses practice, including homes, schools, workplaces, clinics, justice settings, and the community. Observational, intervention, and implementation research are of interest.

Applications NOT responsive to this NOFO

  • Projects that are exclusively qualitative.
  • Projects that include populations living outside the 50 states, tribal lands, and the U.S. territories.
  • Projects that do not study have an intersectional (i.e., race/ethnicity or low SES) focus on the study of health and healthcare among people with disabilities.
  • Studies that focus on disabilities that are outside the definition and scope described in the Key Definitions section above.
  • Projects that include prohibited policy lobbying or advocacy activities (see for more information).
  • Projects that examine the financing of health care or the cost and efficiency of health care service delivery, without linking such economic analysis to measurable health outcomes (See NOT-OD-16-025 for more information).

Non-responsive applications will not be reviewed. Applicants are strongly encouraged to reach out to the relevant scientific contacts to discuss whether their applications are responsive.

See Section VIII. Other Information for award authorities and regulations.

Investigators proposing NIH-defined clinical trials may refer to the Research Methods Resources website for information about developing statistical methods and study designs.

Section VII. Agency Contacts

We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.

Application Submission Contacts

eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date, and post-submission issues)

Finding Help Online: (preferred method of contact)
Telephone: 301-402-7469 or 866-504-9552 (Toll Free)

General Grants Information (Questions regarding application instructions, application processes, and NIH grant resources)
Email: (preferred method of contact)
Telephone: 301-480-7075 Customer Support (Questions regarding registration and Workspace)
Contact Center Telephone: 800-518-4726

Scientific/Research Contact(s)

Sundania J. W. Wonnum, PhD, LCSW

Cheryse A. Sankar, PhD
National Institute on Neurological Disorders and Stroke (NINDS)
Phone: (301) 318-2889

Laura Kwako, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-451-8507

Cheri Wiggs
Phone: (301) 402-0276

Lucia Hindorff, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 240-271-1509

Toyin Ajisafe, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-827-9242

Moria Fisher Bittmann
Phone: none

Christopher Barnhart, PhD
Sexual & Gender Minority Research Office (SGMRO)
Telephone: 301-594-8983

Liz Perruccio, MS, PhD
National Institute of Nursing Research (NINR)
Telephone: 301-402-8084

Yan Wang, MD, PhD
Phone: 301-594-5032

Holly Lynn Storkel
Phone: 301.451.6842

Priscilla Novak, Ph.D.
Phone: 301-496-3136

Wendy Nelson
National Cancer Institute (NCI)
Phone: (240) 276-6971

Peer Review Contact(s)

Examine your eRA Commons account for review assignment and contact information (information appears two weeks after the submission due date).

Financial/Grants Management Contact(s)

Priscilla Grant, J.D.
National Institute on Minority Health and Health Disparities (NIMHD)
Telephone: 301-594-8412

Chief Grants Management Officer
National Institute of Neurological Disorders and Stroke (NINDS)

Judy Fox
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-4704

Karen Robinson Smith
Phone: 301-435-8178

Deanna L. Ingersoll
National Human Genome Research Institute (NHGRI)
Telephone: 301-435-7858

Margaret Young
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-642-4552

Mutema Nyankale
Phone: (301) 827-6317

Ron Wertz
National Institute of Nursing Research (NINR)
Telephone: 301-594-2807

Erik Edgerton
Phone: 301-594-7760

Christopher Myers
Phone: (301) 435-0713

Jeni Smits

Crystal Wolfrey
National Cancer Institute (NCI)
Phone: 240-276-6277


Please direct all inquiries to:

Lucia Hindorff, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 240-271-1509